1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. PCI Pharma Services Acquires Althea

M&A Deal Summary

PCI Pharma Services Acquires Althea

On April 24, 2025, PCI Pharma Services acquired life science company Althea from Ajinomoto

Acquisition Highlights
  • This is PCI Pharma Services’ 3rd transaction in the Life Science sector.
  • This is PCI Pharma Services’ 4th transaction in the United States.
  • This is PCI Pharma Services’ 2nd transaction in California.

M&A Deal Summary
Date 2025-04-24
Target Althea
Sector Life Science
Buyer(s) PCI Pharma Services
Sellers(s) Ajinomoto
Deal Type Divestiture

Target

Althea

San Diego, California, United States
Althea is a fully integrated, contract development and manufacturing organization providing clinical and commercial product development services. The company offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, complex formulation, product release, and ICH-compliant stability testing. Its formulation technology platform includes Crystalomics, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Althea is based in San Diego, California.

Search 207,728 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PCI Pharma Services

Philadelphia, Pennsylvania, United States
Category Company
Founded 2012
Sector Life Science
DESCRIPTION

PCI Pharma Services is a provider of outsourced pharmaceutical supply chain solutions supporting biotechnology and pharmaceutical companies throughout the various stages of drug development and commercialization. PCI Pharma Services was founded in 2012 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 9 of 9
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 1 of 1
State: California M&A 2 of 2
Country: United States M&A 4 of 4
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-29 Bellwyck

Toronto, Ontario, Canada

Bellwyck is a manufacturer of solid dose tablet feed systems, blister and bottle filling, and tablet counting machines serving the pharmaceutical industry. Bellwyck Packaging Solutions was formed in 2007 and is based in Toronto, Ontario.

Sell -

Seller(S) 1

SELLER

Ajinomoto

Tokyo, Japan
Category Company
Founded 1909
Sector Food
Employees34,862
Revenue 1.44T JPY (2024)
DESCRIPTION

Ajinomoto is a manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. Ajinomoto was incorporated in 1909 and is based in Tokyo, Japan.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-24 Enhanced Medical Nutrition

Toronto, Ontario, Canada

Enhanced Medical Nutrition commercializes evidence-based products to support postsurgery physical recovery, and is dedicated to pioneering a new standard of care where nutrition therapy is leveraged to reduce risks of complications, accelerate recovery, and enhance overall patient outcomes. Enhanced Medical Nutrition was formed in 2016 and is based in Toronto, Ontario.

Buy -
Mergr

Solution for

Product

Company

Legal